Literature DB >> 34082769

Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases.

Dongha Kim1, Keun Il Kim2, Sung Hee Baek3.   

Abstract

Lysine-specific demethylase 1 (LSD1) targets mono- or di-methylated histone H3K4 and H3K9 as well as non-histone substrates and functions in the regulation of gene expression as a transcriptional repressor or activator. This enzyme plays a pivotal role in various physiological processes, including development, differentiation, inflammation, thermogenesis, neuronal and cerebral physiology, and the maintenance of stemness in stem cells. LSD1 also participates in pathological processes, including cancer as the most representative disease. It promotes oncogenesis by facilitating the survival of cancer cells and by generating a pro-cancer microenvironment. In this review, we discuss the role of LSD1 in several aspects of cancer, such as hypoxia, epithelial-to-mesenchymal transition, stemness versus differentiation of cancer stem cells, as well as anti-tumor immunity. Additionally, the current understanding of the involvement of LSD1 in various other pathological processes is discussed.

Entities:  

Keywords:  Cancer; Hypoxia; Immunity; Inflammation; Neurodegenerative diseases

Year:  2021        PMID: 34082769     DOI: 10.1186/s12929-021-00737-3

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  115 in total

Review 1.  Histone modifications in transcriptional regulation.

Authors:  Shelley L Berger
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

2.  Regulation of LSD1 histone demethylase activity by its associated factors.

Authors:  Yu-Jiang Shi; Caitlin Matson; Fei Lan; Shigeki Iwase; Tadashi Baba; Yang Shi
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

3.  Opposing LSD1 complexes function in developmental gene activation and repression programmes.

Authors:  Jianxun Wang; Kathleen Scully; Xiaoyan Zhu; Ling Cai; Jie Zhang; Gratien G Prefontaine; Anna Krones; Kenneth A Ohgi; Ping Zhu; Ivan Garcia-Bassets; Forrest Liu; Havilah Taylor; Jean Lozach; Friederike L Jayes; Kenneth S Korach; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Nature       Date:  2007-03-28       Impact factor: 49.962

Review 4.  Crosstalk among Histone Modifications.

Authors:  Tamaki Suganuma; Jerry L Workman
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

Review 5.  A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.

Authors:  Amir Hosseini; Saverio Minucci
Journal:  Epigenomics       Date:  2017-07-12       Impact factor: 4.778

6.  Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase.

Authors:  Maojun Yang; Christian B Gocke; Xuelian Luo; Dominika Borek; Diana R Tomchick; Mischa Machius; Zbyszek Otwinowski; Hongtao Yu
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

7.  Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.

Authors:  Yujiang Shi; Fei Lan; Caitlin Matson; Peter Mulligan; Johnathan R Whetstine; Philip A Cole; Robert A Casero; Yang Shi
Journal:  Cell       Date:  2004-12-29       Impact factor: 41.582

8.  An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation.

Authors:  Min Gyu Lee; Christopher Wynder; Neil Cooch; Ramin Shiekhattar
Journal:  Nature       Date:  2005-08-03       Impact factor: 49.962

9.  LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.

Authors:  Eric Metzger; Melanie Wissmann; Na Yin; Judith M Müller; Robert Schneider; Antoine H F M Peters; Thomas Günther; Reinhard Buettner; Roland Schüle
Journal:  Nature       Date:  2005-08-03       Impact factor: 49.962

10.  The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.

Authors:  Jing Wang; Sarah Hevi; Julia K Kurash; Hong Lei; Frédérique Gay; Jeffrey Bajko; Hui Su; Weitao Sun; Hua Chang; Guoliang Xu; François Gaudet; En Li; Taiping Chen
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

View more
  10 in total

1.  Salinomycin suppresses T24 cells by regulating KDM1A and the unfolded protein response pathway.

Authors:  Haofeng Yuan; Yiqian Li; Yun Zou; Chongyue Cai; Xiangmin Shi; Yanfeng Su
Journal:  Cytotechnology       Date:  2022-09-06       Impact factor: 2.040

Review 2.  Role of NAD+ and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.

Authors:  Parimala Narne; Prakash Babu Phanithi
Journal:  Cell Mol Neurobiol       Date:  2022-09-30       Impact factor: 4.231

3.  Direct hOGG1-Myc interactions inhibit hOGG1 catalytic activity and recruit Myc to its promoters under oxidative stress.

Authors:  Disha M Bangalore; Ingrid Tessmer
Journal:  Nucleic Acids Res       Date:  2022-10-14       Impact factor: 19.160

4.  KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis.

Authors:  Lingyue Li; Yiyu Wang; Yuan Mou; Hao Wu; Ye Qin
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-09       Impact factor: 2.471

5.  Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia.

Authors:  Noureldien H E Darwish; Gennadi V Glinsky; Thangirala Sudha; Shaker A Mousa
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

6.  Epigenetic modification mechanism of histone demethylase KDM1A in regulating cardiomyocyte apoptosis after myocardial ischemia-reperfusion injury.

Authors:  Lin He; Yanbo Wang; Jin Luo
Journal:  PeerJ       Date:  2022-08-05       Impact factor: 3.061

7.  Lysine-specific demethylase 1 aggravated oxidative stress and ferroptosis induced by renal ischemia and reperfusion injury through activation of TLR4/NOX4 pathway in mice.

Authors:  Ruikang Feng; Yufeng Xiong; Yourong Lei; Qin Huang; Hao Liu; Xiaojie Zhao; Zhiyuan Chen; Hui Chen; Xiuheng Liu; Lei Wang; Xiaodong Weng
Journal:  J Cell Mol Med       Date:  2022-06-30       Impact factor: 5.295

8.  Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis.

Authors:  Fernando Cavalcanti; Elena Gonzalez-Rey; Mario Delgado; Clara P Falo; Leyre Mestre; Carmen Guaza; Francisco O'Valle; Michele M P Lufino; Jordi Xaus; Cristina Mascaró; Serena Lunardi; Natalia Sacilotto; Paola Dessanti; David Rotllant; Xavier Navarro; Mireia Herrando-Grabulosa; Carlos Buesa; Tamara Maes
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

9.  Editorial: Epigenetics of the immune component of inflammation.

Authors:  Yan-Jun Liu; Haitao Wang; Hai-Jing Zhong; Cheong-Meng Chong; Guan-Jun Yang
Journal:  Front Immunol       Date:  2022-08-22       Impact factor: 8.786

Review 10.  A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance.

Authors:  Guan-Jun Yang; Yan-Jun Liu; Li-Jian Ding; Fan Tao; Ming-Hui Zhu; Zhen-Yuan Shi; Juan-Ming Wen; Meng-Yao Niu; Xiang Li; Zhan-Song Xu; Wan-Jia Qin; Chen-Jie Fei; Jiong Chen
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.